Литература

1. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors / S. Schneeweiss [et al.] // New Engl. J. Med. — 2002. — Vol. 346, № 11. — P. 822–829.

2. McKenzie, D. B. Drug therapy in chronic heart failure / D. B. McKenzie, A. J. Couley // Post-grad. Med. J. — 2003. — Vol. 79. — P. 634–642.

3. Philbin, E. F. Use of angiotensin — converting enzyme inhibitors in heart failure with preserved left ventricular systolic function / E. F. Philbin, Jr. T. A. Rocco // American Heart Journal. — 1997. — Vol. 134 (part1). — P. 188–195.

4. Erbas, T. Metabolic syndrome / T. Erbas // Acta Diabetol. — 2003. — № 40. — P. 401–404.

5. Gender difference in diastolic function in hypertension / J. N. Bella [et al.] // Amer. J. Cardiol. — 2002. — Vol. 89, № 1. — P. 1052–1056.

УДК 616.36-004-07-039.57